Novo Nordisk’s B shares are listed on Nasdaq Copenhagen in trading units of DKK 0.20 and its ADRs that equals B-shares of DKK 0.20 are listed on New York Stock Exchange (NYSE). 

In order to secure liquidity for both the Novo Nordisk B shares and American Depositary Receipts (ADRs) and bring price levels in line with market practice for especially the ADRs, the Board of Directors has decided to split the trading units in a two-for-one ratio.

The trading unit of the Novo Nordisk B shares listed on NASDAQ Copenhagen was changed from DKK 0.20 to DKK 0.10 as of 13 September 2023. The ADRs listed on the New York Stock Exchange (NYSE) were similarly split as of 20 September 2023 to ensure that the ratio of B shares to ADRs will remain 1:1.

Novo Nordisk’s total share capital of DKK 451,000,000 is divided into an A share capital of nominally DKK 107,487,200 and a B share capital of nominally DKK 343,512,800.

After the split, the total number of A shares of nom. DKK 0.10 is 1,074,872,000 shares. Each A-share of nom. DKK 0,10 carries 100 votes. Consequently, the total number of votes relating to the A shares is 107,487,200,000 votes.

After the split, the total number of B shares of nom. DKK 0.10 is 3,435,128,000 shares. Each B-share of nom. DKK 0,10 carries 10 votes. Consequently, the total number of votes relating to the B shares is 34,351,280,000 votes.

Computershare A/S, Lottenborgvej 26, 2800 Kgs. Lyngby, Denmark

J.P. Morgan, Shareowner Services, P.O. Box 64504, St. Paul, MN 55164-0504

  • Website: www.shareowneronline.com
  • General: +1 800 990 1135
  • From outside the U.S: +1 651 453 2128
  • Global Invest Direct: +1 800 428 4237

Please find the company announcement regarding the stock split  here

ABG Sundal Collier
Morten Larsen morten.larsen@abgsc.dk

Bank of America Merrill Lync
Sachin Jain s.jain@bofa.com

Barclays Capital
Emily Field emily.field@barclays.com

Berenberg
Kerry Holford kerry.holford@berenberg.com

Bernstein
Wimal Kapadia wimal.kapadia@bernstein.com

Carnegie Bank
Jesper Ilsøe jesper.ilsoe@carnegie.dk

Citigroup
Peter Verdult peter.verdult@citi.com

Cowen
Michael Nedelcovych michael.nedelcovych@cowen.com

Credit Suisse
Jo Walton jo.walton@credit-suisse.com

Danske Bank
Thomas Bowers thomas.bowers@danskebank.dk

Deutsche Bank
Emmanuel Papadakis emmanuel.papadakis@db.com

DNB Markets
Rune Majlund Dahl rune.dahl@dnb.no

Exane BNP Paribas
Richard Parkes richard.parkes@exanebnpparibas.com

Goldman Sachs
Keyur Parekh keyur.parekh@gs.com

Guggenheim
Seamus Fernadez seamus.fernandez@guggenheimpartners.com

Handelsbanken
Mattias Häggblom mattias.haggblom@handelsbanken.se

Intron Health
Naresh Chouhan naresh@intronhealthresearch.com

J.P. Morgan
Richard Vosser richard.vosser@jpmorgan.com

Jefferies & Company
Peter Welford pwelford@jefferies.com

Jyske Bank
Henrik Hallengreen Laustsen hla@jyskebank.dk

Kepler Cheuvreux
David Evans devans@keplercheuvreux.com

Morgan Stanley
Mark Purcell mark.purcell@morganstanley.com

Nordea Markets
Michael Novod michael.novod@nordea.com

Nykredit
Michael Drøscher Jørgensen midj@nykredit.dk

Oddo Securities
Martial Descoutures martial.descoutures@oddo-bhf.com

Redburn Partners
Simon Baker simon.baker@redburn.com

SEB
Martin Parkhøi martin.parkhoi@seb.dk

Société Générale
Florent Cespedes florent.cespedes@sgcib.com

Sydbank
Søren Løntoft Hansen s.loentoft@sydbank.dk

UBS
Michael Leuchten michael-a.leuchten@ubs.com

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Cover page of the Novo Nordisk Annual Report 2022

Annual Report 2022

Download Annual Report